« Previous
Next »
Titles
- Mavacamten for hypertrophic cardiomyopathy: effectiveness and value : final evidence report and meeting summary1
- Medications for obesity management: effectiveness and value : final evidence report1
- Mepolizumab (Nucala??, GlaxoSmithKline plc.) for the treatment of severe asthma with eosinophilia: effectiveness, value, and value-based price benchmarks : final report1
- Modulator treatments for cystic fibrosis: effectiveness and value1